Moreover, our results from the ELISA cohort indicate that IL8 could be used to differentiate patients with CIDP and PDN from those with non-inflammatory polyneuropathies (NIP), but due to the low number of patients with PDN, this should be further investigated in a larger cohort. Here, CXCL8 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.